混合抗生素针对细菌的核糖体
Seul Ki Yeon1, Jenna Pellegrino2, Tushar Raskar2
1Department of Pharmaceutical Chemistry, Cardiovascular Research Institute, University of CaliforniaSan Francisco, San Francisco, California 94158, United States.
ACS central science
|December 4, 2025
概括
科学家们通过结合现有药物来设计了新的混合抗生素,以对抗抗菌素耐药性. 一个有前途的混合物,阿齐思罗米和泰迪索利德,通过抑制细菌核糖体,有效地准多药耐药细菌.
科学领域:
- 微生物学 微生物学
- 结构生物学 结构生物学
- 药用化学 医学化学
背景情况:
- 抗菌素耐药性 (AMR) 是一个主要的全球健康威胁,耐药性机制超过了新抗生素的发展.
- 需要新的策略来克服现有的耐药性,并开发新的抗菌剂.
- 针对细菌核糖体上多个部位的混合抗生素提供了一个有希望的方法.
研究的目的:
- 设计,合成和描述针对细菌核糖体的新型混合抗生素.
- 通过结构生物学技术研究这些混合抗生素的分子作用机制.
- 为了确定有效对抗多药耐药细菌的强效混合抗生素.
主要方法:
- 混合抗生素的合理设计和合成,结合了阿齐思罗素,泰迪索利德和氨基醇.
- 对一组多药耐药细菌进行微生物学评估.
- 低温电子显微镜测定了核糖体与混合抗生素相互作用的结构基础.
主要成果:
- 针对核糖体的基转移酶中心 (PTC) 和新生基退出道 (NPET) 的四种新型混合抗生素被合成和特征化.
- 低温电子显微镜为这些混合体的结合模式提供了详细的结构洞察.
- 阿齐思罗米和泰迪索利德的混合体对抗多药耐药的格拉姆阳性细菌表现出广泛的活性,并且对核糖体保护 (ABC-F) 耐药机制有效.
结论:
- 针对相邻的核糖体位点的混合抗生素的合理设计是克服抗菌素耐药性的可行策略.
- 鉴定到的阿齐思罗米-泰迪索利德混合体代表了一种有前途的双重作用抗生素新类,具有潜在的临床应用.
- 这项工作为开发针对细菌点的双功能抑制剂提供了框架.
相关概念视频
Combined Effects of Drugs: Synergism
6.7K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
6.7K
Types of RNA
72.4K
Overview
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
72.4K
Coordination of Gene Expression Processes in Bacteria
547
The DNA replication, transcription, and translation processes are intricately coupled in bacteria, allowing efficient gene expression and rapid protein synthesis. While this physical and functional coordination is advantageous, it introduces challenges that bacteria overcome through specific regulatory mechanisms.Coupling of Replication, Transcription, and TranslationThe coupling of replication, transcription, and translation is a hallmark of bacterial gene expression. As the replisome unwinds...
547
Development of Antibiotic Resistance
1.2K
Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
1.2K
Antibiotic Selection
59.3K
Overview
59.3K
Translational Regulation
508
Translational regulation in prokaryotes ensures efficient protein synthesis by controlling ribosome access to mRNA. This regulation is mediated by secondary RNA structures, including translational riboswitches, RNA thermometers, and small RNAs (sRNAs), which respond to intracellular and environmental signals to modulate gene expression.Translational RiboswitchesRiboswitches in the leader region of mRNAs can regulate translation by altering the accessibility of the Shine-Dalgarno (SD) sequence,...
508


